CA2543986C - Inhibiteurs de recapture de la noradrenaline et methodes d'utilisation connexes - Google Patents

Inhibiteurs de recapture de la noradrenaline et methodes d'utilisation connexes Download PDF

Info

Publication number
CA2543986C
CA2543986C CA002543986A CA2543986A CA2543986C CA 2543986 C CA2543986 C CA 2543986C CA 002543986 A CA002543986 A CA 002543986A CA 2543986 A CA2543986 A CA 2543986A CA 2543986 C CA2543986 C CA 2543986C
Authority
CA
Canada
Prior art keywords
reboxetine
disorder
norepinephrine
reuptake
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002543986A
Other languages
English (en)
Other versions
CA2543986A1 (fr
Inventor
Erik H.F. Wong
Saeeduddin Ahmed
Robert Clyde Marshall
Robert Mcarthur
Duncan P. Taylor
Lars Birgerson
Pasquale Cetera
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co filed Critical Pharmacia and Upjohn Co
Priority to CA002643231A priority Critical patent/CA2643231A1/fr
Priority claimed from CA002375908A external-priority patent/CA2375908C/fr
Publication of CA2543986A1 publication Critical patent/CA2543986A1/fr
Application granted granted Critical
Publication of CA2543986C publication Critical patent/CA2543986C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002543986A 1999-07-01 2000-06-22 Inhibiteurs de recapture de la noradrenaline et methodes d'utilisation connexes Expired - Fee Related CA2543986C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002643231A CA2643231A1 (fr) 1999-07-01 2000-06-22 Inhibiteurs de recapture de la noradrenaline et methodes d'utilisation connexes

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US14196899P 1999-07-01 1999-07-01
US60/141,968 1999-07-01
US14413199P 1999-07-16 1999-07-16
US60/144,131 1999-07-16
US15825699P 1999-10-06 1999-10-06
US60/158,256 1999-10-06
US17038199P 1999-12-13 1999-12-13
US60/170,381 1999-12-13
CA002375908A CA2375908C (fr) 1999-07-01 2000-06-22 Inhibiteurs de recaptage de noradrenaline hautement selectifs et leurs methodes d'utilisation

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002375908A Division CA2375908C (fr) 1999-07-01 2000-06-22 Inhibiteurs de recaptage de noradrenaline hautement selectifs et leurs methodes d'utilisation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA002643231A Division CA2643231A1 (fr) 1999-07-01 2000-06-22 Inhibiteurs de recapture de la noradrenaline et methodes d'utilisation connexes

Publications (2)

Publication Number Publication Date
CA2543986A1 CA2543986A1 (fr) 2001-01-11
CA2543986C true CA2543986C (fr) 2009-03-03

Family

ID=36141768

Family Applications (2)

Application Number Title Priority Date Filing Date
CA002543986A Expired - Fee Related CA2543986C (fr) 1999-07-01 2000-06-22 Inhibiteurs de recapture de la noradrenaline et methodes d'utilisation connexes
CA002532330A Expired - Fee Related CA2532330C (fr) 1999-07-01 2000-06-22 Inhibiteurs de recaptage de noradrenaline hautement selectifs et leurs methodes d'utilisation

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA002532330A Expired - Fee Related CA2532330C (fr) 1999-07-01 2000-06-22 Inhibiteurs de recaptage de noradrenaline hautement selectifs et leurs methodes d'utilisation

Country Status (1)

Country Link
CA (2) CA2543986C (fr)

Also Published As

Publication number Publication date
CA2543986A1 (fr) 2001-01-11
CA2532330C (fr) 2009-04-21
CA2532330A1 (fr) 2001-01-11

Similar Documents

Publication Publication Date Title
CA2375908C (fr) Inhibiteurs de recaptage de noradrenaline hautement selectifs et leurs methodes d'utilisation
EP1500395A1 (fr) Reboxétine pour traiter les fibromyalgies et d'autres troubles somatoformes
CA2543986C (fr) Inhibiteurs de recapture de la noradrenaline et methodes d'utilisation connexes
NZ542816A (en) Optically pure (S.S) reboxetine in the treatment of conditions such as those involving addiction and TIC disorders in which inhibiting reuptake of norepinephrine (nor adrenaline) provides relief
NZ550213A (en) Use of racemic reboxetine for the treatment of chronic fatigue syndrome, fibromyalgia or another somatoform disorder, migraine headaches and peripheral neuropathy

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed